Remedium Capital Partners, LLC
- SEC CIK
- 0002104501
- Latest filing
- Aug 7, 2026
Holdings in Q2 2026
Holdings as of Jun 30, 2026, filed Aug 7, 2026. Long positions only; changes compare share counts with Q1 2026.
- Positions
- 6
- 0 vs. Q1 2026
- Portfolio value
- $451.6M
- +$170.5M (+60.6%) vs. Q1 2026
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| ORKAOruka Therapeutics, Inc. | COM | 1,565,661 | $149.0M | 33.0% | 00.0% | Unchanged | History |
| SYRESpyre Therapeutics, Inc. | COM NEW | 1,464,169 | $130.0M | 28.8% | +7,938+0.5% | Added | History |
| APGEApogee Therapeutics, Inc. | COM | 586,691 | $77.9M | 17.2% | +3,100+0.5% | Added | History |
| DMRADamora Therapeutics, Inc. | COM NEW | 2,045,473 | $53.2M | 11.8% | 00.0% | Unchanged | History |
| JBIOJade Biosciences, Inc. | COM NEW | 1,577,750 | $35.1M | 7.8% | 00.0% | Unchanged | History |
| CBIOCrescent Biopharma, Inc. | COM | 361,250 | $6.50M | 1.4% | +361,250 | New | History |
Sold out since Q1 2026 (1)
Positions held at the end of Q1 2026 that are gone from this filing.